This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2011-2016.
Company Filing History:
Years Active: 2011-2016
Title: Andrej Kocijan: Innovator in Pharmaceutical Chemistry
Introduction
Andrej Kocijan is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of atorvastatin calcium and its oxidative degradation products. With a total of 2 patents, Kocijan's work has implications for the pharmaceutical industry and patient care.
Latest Patents
Kocijan's latest patents focus on the oxidative degradation products of atorvastatin calcium. The first patent details the oxidative degradation products and the process of their preparation. It also discusses atorvastatin calcium that is substantially free of these degradation products, along with the pharmaceutical compositions containing such atorvastatin calcium. The second patent reiterates similar findings, emphasizing the importance of purity in atorvastatin calcium formulations.
Career Highlights
Andrej Kocijan is currently associated with Lek Pharmaceuticals D.d., a leading pharmaceutical company in Slovenia. His work at Lek has allowed him to explore innovative solutions in drug formulation and stability, contributing to the advancement of pharmaceutical sciences.
Collaborations
Kocijan has collaborated with several professionals in his field, including Rok Grahek and Darko Kocjan. These collaborations have fostered a productive environment for research and development, enhancing the quality of their collective work.
Conclusion
Andrej Kocijan's contributions to pharmaceutical chemistry, particularly through his patents on atorvastatin calcium, highlight his role as an innovator in the industry. His work not only advances scientific knowledge but also has practical applications in improving patient outcomes.